Tasigna
Term · Oncology and biomedicine · MLC-T-ONC-008530
A drug used to treat certain types of chronic myelogenous leukemia that are Philadelphia chromosome positive. It is also being studied in the treatment of other types of cancer. Tasigna blocks BCR::ABL1 and other proteins, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called nilotinib.
| Identifier | MLC-T-ONC-008530 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | nilotinib |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-008530",
"term": "Tasigna",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat certain types of chronic myelogenous leukemia that are Philadelphia chromosome positive. It is also being studied in the treatment of other types of cancer. Tasigna blocks BCR::ABL1 and other proteins, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called nilotinib.",
"synonyms": [
"nilotinib"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/tasigna/"
}
Record 16,012 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.